Skip to main content

Table 3 Clinical inquiries from DR-TB treatment sites and recommendations of the consilium

From: Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda

 

Count (%)

Clinical inquiries from DR-TB sites (N = 308)

Construction of treatment regimen

119 (38.6)

Management of adverse effect

74 (24.0)

Determination treatment duration

67 (21.8)

Validation of already prescribed regimen

30 (9.7)

Establishment of DR-TB diagnosis

17 (5.5)

Unknown

1 (0.3)

Recommendations of consilium (N = 471)

Construction of initial DR-TB regimen

102 (21.7)

Observation while on current regimen

78 (16.6)

Adherence counselling

66 (14.0)

Dose adjustment

36 (7.6)

Further diagnostic work up

35 (7.4)

Further clinical evaluation by specialist

32 (6.8)

Substitution of single agent in the regimen

30 (6.4)

Change of regimen (substituting 2 or more agents)

25 (5.3)

Adjunct medication

23 (4.9)

Withholding a single agent without substituting it

15 (3.2)

Withholding all DR-TB treatment for a while

13 (2.8)

Other recommendation

16 (3.4)

  1. DR-TB–drug resistant tuberculosis